ArticleMedChemComm2019
Development of hydroxamate-based histone deacetylase inhibitors of bis-substituted aromatic amides with antitumor activities.
Di Ge et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it